| 4 |
| VANGUARD CAPITAL MANAGEMENT LLC |
| 1.4M |
| $59.0M |
| +4.9% |
| 2.285% |
| 0.00% |
| 5 | Woodline Partners LP | 1.3M | $53.3M | 0.0% | 2.063% | 0.16% |
| 6 | LOOMIS SAYLES & CO L P | 1.1M | $43.7M | +23.1% | 1.691% | 0.06% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 950K | $38.7M | +46.9% | 1.500% | 0.00% |
| 8 | FRANKLIN TEMPLETON INC | 862K | $36.3M | -10.8% | 1.361% | 0.01% |
| 9 | Valiant Capital Management, L.P. | 803K | $32.8M | -32.3% | 1.269% | 1.65% |
| 10 | TimesSquare Capital Management, LLC | 777K | $31.7M | -18.3% | 1.228% | 0.52% |
| 11 | STATE STREET CORP | 773K | $31.5M | +31.0% | 1.221% | 0.00% |
| 12 | BOONE CAPITAL MANAGEMENT LLC | 725K | $29.6M | +1.8% | 1.145% | 7.85% |
| 13 | DIMENSIONAL FUND ADVISORS LP | 641K | $26.1M | +24.2% | 1.012% | 0.00% |
| 14 | FIRST TRUST ADVISORS LP | 601K | $24.5M | +30.3% | 0.950% | 0.01% |
| 15 | Boston Partners | 523K | $21.4M | -46.9% | 0.826% | 0.02% |
| 16 | JENNISON ASSOCIATES LLC | 511K | $20.9M | -18.4% | 0.808% | 0.01% |
| 17 | DRIEHAUS CAPITAL MANAGEMENT LLC | 502K | $20.5M | -1.6% | 0.793% | 0.14% |
| 18 | ROYAL BANK OF CANADA | 463K | $18.9M | +53.5% | 0.731% | 0.00% |
| 19 | BRAUN STACEY ASSOCIATES INC | 398K | $16.2M | +17.1% | 0.628% | 0.47% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 387K | $15.8M | +50.0% | 0.612% | 0.00% |
| 21 | Aristotle Capital Boston, LLC | 327K | $13.3M | -22.7% | 0.516% | 1.18% |
| 22 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 314K | $12.8M | -9.0% | 0.496% | 0.09% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 302K | $12.3M | +401.7% | 0.476% | 0.00% |
| 24 | NORTHERN TRUST CORP | 299K | $12.2M | +41.5% | 0.472% | 0.00% |
| 25 | Alyeska Investment Group, L.P. | 287K | $11.7M | +4.2% | 0.453% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in GRDN — a direct measure of their conviction.
| 45.20% |
| +19.70 pp |
| $371M |
| +71% |
| Q1 2025 | 75 | +12% | 25.50% | +7.63 pp | $217M | +18% |
| Q4 2024 | 67 | — | 17.87% | — | $184M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
29 institutions opened new positions in GRDN during Q3 2026, while 21 fully exited. 78 added to existing positions and 85 trimmed.
GRDN institutional ownership rose by 1.14 percentage points quarter-over-quarter, with a net change of +10 holders.
The top 10 institutions account for 54.8% of all reported 13F value in GRDN, and the top 25 account for 80.2%.
Across the largest Drug Distributors & Pharmacies peers, institutional ownership levels are: MEDS (1.5%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.